High prevalence of HIV-1 transmitted drug-resistance mutations from proviral DNA massively parallel sequencing data of therapy-naïve chronically infected Brazilian blood donors

Sharp increase in rates of HIV transmitted drug resistance at antenatal clinics in Botswana demonstrates the need for routine surveillance

(2016) C. F. Rowley et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Ultra-Deep Sequencing of HIV-1 near Full-Length and Partial Proviral Genomes Reveals High Genetic Diversity among Brazilian Blood Donors

(2016) Rodrigo Pessôa et al.   PLoS One

HIV-1 Drug Resistance Surveillance in Antiretroviral Treatment-Naive Individuals from a Reference Hospital in Guatemala, 2010–2013

(2015) Santiago Avila-Ríos et al.   AIDS RESEARCH AND HUMAN RETROVIRUSES

Global HIV-1 transmitted drug resistance in the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial

(2015) JD Baxter et al.   HIV MEDICINE

Trends in use of genotypic resistance testing and frequency of major drug resistance among antiretroviral-naive persons in the HIV Outpatient Study, 1999–2011

(2015) Kate Buchacz et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Deep Sequencing of HIV: Clinical and Research Applications

(2014) Shiven B. Chabria et al.   Annual Review of Genomics and Human Genetics

Sensitive Deep-Sequencing-Based HIV-1 Genotyping Assay To Simultaneously Determine Susceptibility to Protease, Reverse Transcriptase, Integrase, and Maturation Inhibitors, as Well as HIV-1 Coreceptor Tropism

(2014) Richard M. Gibson et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Deep Sequencing of HIV-1 near Full-Length Proviral Genomes Identifies High Rates of BF1 Recombinants Including Two Novel Circulating Recombinant Forms (CRF) 70_BF1 and a Disseminating 71_BF1 among Blood Donors in Pernambuco, Brazil

(2014) Rodrigo Pessôa et al.   PLoS One

Cross-clade simultaneous HIV drug resistance genotyping for reverse transcriptase, protease, and integrase inhibitor mutations by Illumina MiSeq

(2014) Dawn M Dudley et al.   Retrovirology

Enhanced detection of viral diversity using partial and near full-length genomes of human immunodeficiency virus Type 1 provirus deep sequencing data from recently infected donors at four blood centers in Brazil

(2014) Rodrigo Pessôa et al.   TRANSFUSION

Characterizing the emergence and persistence of drug resistant mutations in HIV-1 subtype C infections using 454 ultra deep pyrosequencing

(2013) Vijay Bansode et al.   BMC INFECTIOUS DISEASES

Transmitted drug-resistance in human immunodeficiency virus-infected adult population in El Salvador, Central America

(2013) Á. Holguín et al.   CLINICAL MICROBIOLOGY AND INFECTION

Non-nucleoside reverse transcriptase inhibitor (NNRTI) cross-resistance: implications for preclinical evaluation of novel NNRTIs and clinical genotypic resistance testing

(2013) George L. Melikian et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Moderate Prevalence of Transmitted Drug Resistance Mutations Among Antiretroviral-Naive HIV-Infected Pregnant Women in Rio de Janeiro, Brazil

(2012) José H. Pilotto et al.   AIDS RESEARCH AND HUMAN RETROVIRUSES

Prevalence of Transmitted Antiretroviral Drug Resistance Differs Between Acutely and Chronically HIV-Infected Patients

(2012) Elizabeth L. Yanik et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Deep Sequencing Reveals Minor Protease Resistance Mutations in Patients Failing a Protease Inhibitor Regimen

(2012) R. Fisher et al.   JOURNAL OF VIROLOGY

Low-Cost Ultra-Wide Genotyping Using Roche/454 Pyrosequencing for Surveillance of HIV Drug Resistance

(2012) Dawn M. Dudley et al.   PLoS One

HIV-1 Genetic Diversity and Transmitted Drug Resistance Mutations among Patients from the North, Central and South Regions of Angola

(2012) Joana Morais Afonso et al.   PLoS One

Next generation deep sequencing and vaccine design: today and tomorrow

(2012) Fabio Luciani et al.   TRENDS IN BIOTECHNOLOGY

Whole Genome Deep Sequencing of HIV-1 Reveals the Impact of Early Minor Variants Upon Immune Recognition During Acute Infection

(2012) Matthew R. Henn et al.   PLoS Pathogens

Low-Frequency HIV-1 Drug Resistance Mutations and Risk of NNRTI-Based Antiretroviral Treatment Failure

(2011) Jonathan Z. Li   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

HIV-1 drug resistance in antiretroviral-naive individuals in sub-Saharan Africa after rollout of antiretroviral therapy: a multicentre observational study

(2011) Raph L Hamers et al.   LANCET INFECTIOUS DISEASES

Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a European multicohort study

(2011) Linda Wittkop et al.   LANCET INFECTIOUS DISEASES

HIV Drug Resistance (HIVDR) in Antiretroviral Therapy-Naïve Patients in Tanzania Not Eligible for WHO Threshold HIVDR Survey Is Dramatically High

(2011) Christa Kasang et al.   PLoS One

Sentinel Surveillance of HIV-1 Transmitted Drug Resistance, Acute Infection and Recent Infection

(2011) Hong-Ha M. Truong et al.   PLoS One

National Prevalence and Trends of HIV Transmitted Drug Resistance in Mexico

(2011) Santiago Avila-Ríos et al.   PLoS One

Role of low-frequency HIV-1 variants in failure of nevirapine-containing antiviral therapy in women previously exposed to single-dose nevirapine

(2011) V. F. Boltz et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

High frequency of integrase Q148R minority variants in HIV-infected patients naive of integrase inhibitors

(2010) Charlotte Charpentier et al.   AIDS

Prevalence of transmitted drug resistance associated mutations and HIV-1 subtypes in new HIV-1 diagnoses, U.S.–2006

(2010) William H Wheeler et al.   AIDS

The M230L Nonnucleoside Reverse Transcriptase Inhibitor Resistance Mutation in HIV-1 Reverse Transcriptase Impairs Enzymatic Function and Viral Replicative Capacity

(2010) H. T. Xu et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Transmission of HIV‐1 Drug‐Resistant Variants: Prevalence and Effect on Treatment Outcome

(2010) Martin R. Jakobsen et al.   CLINICAL INFECTIOUS DISEASES

Transmitted drug resistance and type of infection in newly diagnosed HIV-1 individuals in Honduras

(2010) Wendy Murillo et al.   JOURNAL OF CLINICAL VIROLOGY

Prevalence of key resistance mutations K65R, K103N, and M184V as minority HIV-1 variants in chronically HIV-1 infected, treatment-naïve patients

(2010) Karin J. Metzner et al.   JOURNAL OF CLINICAL VIROLOGY

Whole-Genome Characterization of Human and Simian Immunodeficiency Virus Intrahost Diversity by Ultradeep Pyrosequencing

(2010) B. N. Bimber et al.   JOURNAL OF VIROLOGY

Clinical management of HIV-1 resistance

(2009) Roger Paredes et al.   ANTIVIRAL RESEARCH

Antiretroviral drug resistance in HIV-infected patients in Colombia

(2009) Carlos A. DiazGranados et al.   INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

Low-Abundance Drug-Resistant Viral Variants in Chronically HIV-Infected, Antiretroviral Treatment–Naive Patients Significantly Impact Treatment Outcomes

(2009) Birgitte B. Simen et al.   JOURNAL OF INFECTIOUS DISEASES

Drug Resistance Mutations for Surveillance of Transmitted HIV-1 Drug-Resistance: 2009 Update

(2009) Diane E. Bennett et al.   PLoS One

Human Immunodeficiency Virus Type 1 Population Genetics and Adaptation in Newly Infected Individuals

(2008) M. Kearney et al.   JOURNAL OF VIROLOGY